-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UTZpPrVaeBO9GQ4sXpy/8OAc9hcNLBuD1chaw1j+mpXh3KWT7gA5dBPuUR5Pon4L SqxUIF4oflnUsfUC4U8COA== 0001181154-03-000002.txt : 20031204 0001181154-03-000002.hdr.sgml : 20031204 20031204093239 ACCESSION NUMBER: 0001181154-03-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031203 FILED AS OF DATE: 20031204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVENPORT FRED B JR CENTRAL INDEX KEY: 0001181154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 031036516 BUSINESS ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC STREET 2: 3151 S 17TH ST CITY: WILMINGTON STATE: DE ZIP: 28412 BUSINESS PHONE: 9102510081 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 4 1 edgar.xml PRIMARY DOCUMENT X0201 42003-12-03 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181154 DAVENPORT FRED B JR 6612 SEDGEWOOD DRIVE WILMINGTON NC 28403 0100PresidentCommon Stock11366DNot ApplicableStock Options (to buy)30.602003-12-034A0400000A2004-12-032013-12-02Common Stock40000282500D8,366 shares are restricted stock e xempt under Section 16(b), Rule 16(b)-3(d)(1) and 2,000 shares are held in a self-directed IRA.13,333 shares will vest on 12/3/04; 13,333 shares will vest on 12/3/05 and 13,334 shares will vest on 12/3/06.Lisa C. Noecker for Fred B. Davenport, Jr.2003-12-04 -----END PRIVACY-ENHANCED MESSAGE-----